tm logo
ORESVOBAN
Live/Pending
NOTICE OF ALLOWANCE - ISSUED

issued

on 10 Dec 2024

Last Applicant/ Owned by

66 Hudson Boulevard East

New York

NY

10001-2192

Serial Number

98457628 filed on 19th Mar 2024

Registration Number

N/A

Correspondent Address

Richard A. Friedman

Richard A. Friedman Pfizer Inc.

Legal-Trademark & Copyright

New York, NY 10001-2192

United States

Filing Basis

1. intent to use

2. intent to use current

Disclaimer

NO DATA

ORESVOBAN

Pharmaceutical preparations for the treatment of autoimmune, cardiovascular, central nervous system, endocrine, gastrointestinal, genetic, infectious, inflammatory, kidney, liver, menopausal, metabolic, musculoskeletal, neurodegenerative, neurological, neuromuscular and viral diseases and disorders; Pharmaceutical preparations for the treatment of blood disorders, bone growth disorders, skin disor Read More

Classification Information


Class [005]
Pharmaceutical Products


Pharmaceutical preparations for the treatment of autoimmune, cardiovascular, central nervous system, endocrine, gastrointestinal, genetic, infectious, inflammatory, kidney, liver, menopausal, metabolic, musculoskeletal, neurodegenerative, neurological, neuromuscular and viral diseases and disorders; Pharmaceutical preparations for the treatment of blood disorders, bone growth disorders, skin disorders, arthritis, cancer, hypertension, pain, stroke, obesity and diabetes; Pharmaceutical preparations, namely, anti-infective preparations, medicated dermatological preparations, and smoking cessation preparations; Vaccines for human use


First Use Date in General

N/A

First Use Date in Commerce

N/A

Mark Details


Serial Number

No 98457628

Mark Type

No Service/Collective Mark

Attorney Docket Number

No T445998

44D Filed

No

44D Current

No

44E filed

No

44E Current

No

66A Filed

No

66A Current

No

Current Basis

No

No Basis

No

Legal History


Status DateAction Taken
10th Dec 2024NOA E-MAILED - SOU REQUIRED FROM APPLICANT
29th Oct 2024OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
29th Oct 2024PUBLISHED FOR OPPOSITION
09th Oct 2024NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
19th Sep 2024ASSIGNED TO EXAMINER
19th Sep 2024APPROVED FOR PUB - PRINCIPAL REGISTER
14th Aug 2024NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
20th Mar 2024NEW APPLICATION ENTERED